Santa Ana Bio, Inc., a precision immunology company developing targeted therapies for patients with autoimmune and inflammatory diseases, today announced the appointment of Mike Bonney as Chair of its Board of Directors.
Santa Ana Bio, Inc., a precision immunology company developing targeted therapies for patients with autoimmune and inflammatory diseases, today announced the appointment of Mike Bonney as Chair of its Board of Directors.


